Last reviewed · How we verify
CAFFEIC ACID
At a glance
| Generic name | CAFFEIC ACID |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis. (PHASE2)
- WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors (PHASE1)
- Pulpotomy Versus Pulpectomy in Vital Primary Incisors (NA)
- The Açaí Berry COVID-19 Anti-Inflammation Trial (PHASE2)
- GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) (PHASE3)
- The Efficacy and Safety of Caffeic Acid for Esophageal Cancer (PHASE3)
- Caffeic Acid Combining High-dose Dexamethasone in Management of ITP (PHASE4)
- Influence of the Composition of Temporary Restorative Material in Vital Teeth (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CAFFEIC ACID CI brief — competitive landscape report
- CAFFEIC ACID updates RSS · CI watch RSS